Medicament for Treating Peripheral Neuropathies
OwnerLily Hsiaoinventor
Life of this patent
Estimating the term…
Abstract
The invention provides a pharmaceutical composition for treating impetigo of a human that is induced by Herpes simplex virus (HSV) or varicella zoster virus (VZV), said pharmaceutical composition comprising an effective amount of 2-[(2-amino-6-oxo-6,9-dihydro-3H-purin-9-yl)methoxy]ethyl-2-amino-3-methylbutanoate and an effective amount of an Anti-allergic agent.
Claims9
A pharmaceutical composition for treating impetigo of a human that is induced by Herpes simplex virus (HSV) or varicella zoster virus (VZV), said pharmaceutical composition comprising an effective amount of 2-[(2-amino-6-oxo-6,9-dihydro-3H-purin-9-yl)methoxy]ethyl-2-amino-3-methylbutanoate and an effective amount of an Anti-allergic agent.
The pharmaceutical composition of claim 5, wherein said pharmaceutical composition comprises Valacyclovir 500 mg and Loratadine 10 mg.
A pharmaceutical composition for treating impetigo of a human that is induced by Herpes simplex virus (HSV) or varicella zoster virus (VZV), said pharmaceutical composition comprising an effective amount of 2-Amino-1,9-dihydro-9-((2-hydroxyethoxy)methyl)-6H-purin-6-one and an effective amount of an Anti-allergic agent.
Dependencies are inferred from the claim text.